Rain Oncology Inc (RAIN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RAIN | AMGN | VRTX | BMY | GILD |
| Company | Rain Oncology Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 1.2400 | 291.50 | 478.56 | 58.16 | 91.71 |
| High | 1.2700 | 291.50 | 479.93 | 58.36 | 91.99 |
| Low | 1.2100 | 279.62 | 458.10 | 55.82 | 88.21 |
| Last | 1.2100 | 283.61 | 465.70 | 56.22 | 88.40 |
| Change | -0.0200 | -12.32 | -18.26 | -2.28 | -3.71 |
| % Change | -1.63% | -4.16% | -3.77% | -3.90% | -4.03% |
| Volume | 3,706,000 | 5,324,700 | 2,581,300 | 21,258,438 | 11,453,500 |
| 20-Day Average Volume | 524,660 | 2,512,550 | 1,196,130 | 11,543,104 | 7,325,820 |
| Previous Close | 1.2300 | 295.93 | 483.96 | 58.50 | 92.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2095 | 313.94 | 483.15 | 54.91 | 90.68 |
| 20-Day Raw Stochastic | 29.41% | 8.20% | 12.30% | 47.57% | 21.05% |
| 20-Day Relative Strength | 55.65% | 28.52% | 44.75% | 56.55% | 50.48% |
| Weighted Alpha | -5.00 | -1.18 | +24.61 | +18.56 | +23.65 |
| Today's Opinion | 40% Buy | 40% Sell | 16% Buy | 100% Buy | 80% Buy |
| Previous Opinion | 40% Buy | 40% Sell | 72% Buy | 100% Buy | 96% Buy |
| Last Month's Opinion | 24% Buy | 24% Buy | 56% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.83% since 01/18/24 | -12.81% since 11/08/24 | -9.88% since 11/08/24 | +3.84% since 11/08/24 | -8.46% since 11/08/24 |
| Low | 1.2000 on 01/19/24 | 279.62 on 11/15/24 | 458.10 on 11/15/24 | 55.82 on 11/15/24 | 88.21 on 11/15/24 |
| High | 1.2700 on 01/25/24 | 327.58 on 11/11/24 | 518.35 on 11/11/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 1-Month | |||||
| %Chg | unch since 12/22/23 | -12.76% since 10/15/24 | -3.84% since 10/15/24 | +6.56% since 10/15/24 | +3.01% since 10/15/24 |
| Low | 1.1850 on 01/02/24 | 279.62 on 11/15/24 | 458.10 on 11/15/24 | 51.81 on 10/28/24 | 85.60 on 10/22/24 |
| High | 1.2700 on 01/25/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +14.15% since 10/25/23 | -12.84% since 08/15/24 | -1.33% since 08/15/24 | +14.48% since 08/15/24 | +18.91% since 08/15/24 |
| Low | 0.9900 on 11/29/23 | 279.62 on 11/15/24 | 447.70 on 10/07/24 | 46.88 on 08/22/24 | 72.89 on 08/16/24 |
| High | 1.2700 on 01/25/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -9.02% since 07/25/23 | -11.11% since 05/15/24 | +6.45% since 05/15/24 | +26.20% since 05/15/24 | +31.92% since 05/15/24 |
| Low | 0.8200 on 10/03/23 | 279.62 on 11/15/24 | 432.22 on 05/16/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 1.3899 on 07/27/23 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 44,015 | 159,072,144 | 124,633,728 | 118,648,352 | 114,793,560 |
| Shares Outstanding, K | 36,376 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -75,720,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -7,030,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 0.27 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 11/09/23 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 03/14/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.68 | 0.00 | 49.92 | 20.91 |